Similar companies
Company | Transaction Value | |
---|---|---|
OcugenOCGN |
-$4.6M | |
AmarinAMRN |
$1.7M | |
Gilead SciencesGILD |
-$254M | |
Anavex Life SciencesAVXL |
-$14M | |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Versant Venture Capital VI, L.P. | Aug 28, 2024 | Sell | 221,600 | $6.3202 | $1.4M |
BB BIOTECH AG | Oct 17, 2023 | Buy | 400,000 | $2.3352 | $930,000 |
Behbahani Ali | Jul 5, 2023 | Buy | 1,000,000 | $5 | $5M |
RA Capital Healthcare Fund LP | Jul 5, 2023 | Buy | 935,850 | $5 | $4.7M |
BB BIOTECH AG | Jun 30, 2023 | Buy | 1,000,000 | $5 | $5M |
BB BIOTECH AG | Jun 27, 2023 | Buy | 1,740,000 | $5.4914 | $9.6M |
Epstein David M. | Jun 27, 2023 | Sell | 25,000 | $6.7 | $170,000 |
What's the latest insider transaction for Black Diamond Therapeutics?
The most recent insider transaction for Black Diamond Therapeutics was conducted by Versant Venture Capital VI, L.P., who sold 221,600 shares on August 28, 2024 at a price of $6.32 per share.
Which insider bought the most BDTX stock over the last two years?
BB BIOTECH AG has bought the most BDTX stock in the last 2 years, with a total value of $15M.
Which insider has sold the most BDTX stock over the last two years?
Versant Venture Capital VI, L.P. has sold the most BDTX stock in the last 2 years, with a total value of $1.4M.
What is the total value of insider transactions for Black Diamond Therapeutics (BDTX) in the last 2 years?
According to our estimates, the total value of insider transactions for Black Diamond Therapeutics in the last 2 years is positive, amounting to $24M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Black Diamond Therapeutics' market confidence?
Over the last 2 years, insider transactions for Black Diamond Therapeutics have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.